.Regeneron is actually back along with long-lasting follow-up for its own LAG-3 inhibitor and also P...
.AstraZeneca has discussed an early look at the efficiency of its internal antibody-drug conjugate (...
.After introducing a period 3 launch based on beneficial midstage outcomes, iTeos and also GSK are a...
.The FDA must be more available and collaborative to release a surge in approvals of uncommon illnes...
.It is actually an extraordinarily occupied Friday for biotech IPOs, with Zenas BioPharma, MBX and a...
.Atea Pharmaceuticals' antiviral has actually stopped working an additional COVID-19 trial, however ...
.Neurocrine Biosciences' mental illness plan pivot has stopped working. The biotech was actually una...
.Sanofi has actually created an overdue entrance to the radioligand gathering, paying for one hundre...
.After F2G's very first attempt to obtain a new class of antifungal to market was actually wrecked b...
.Moderna has actually pledged to cut R&D costs by $1.1 billion through 2027. The choice to shrink...